GSID - ETF AI Analysis
Top Page
Goldman Sachs MarketBeta International Equity ETF (GSID)
Rating:66Neutral
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has delivered steady gains so far this year, supported by positive returns over the past month and quarter.
Global Diversification Outside the U.S.
Holdings spread across many countries such as Japan, the UK, and several European and Asia-Pacific markets help reduce reliance on any single economy.
Reasonable Expense Ratio
The fund’s management fee is relatively low for an actively managed international equity ETF, allowing more of the returns to stay with investors.
Negative Factors
Country Concentration in Japan and the UK
A large share of assets is invested in Japan and the UK, which could hurt returns if either of these markets struggles.
Mixed Performance Among Top Holdings
While some leading positions like ASML, HSBC, and Shell have shown strong or steady gains, others such as Nestlé, Roche, and Toyota have been weak, creating uneven contribution to returns.
Significant Financial Sector Exposure
A sizable allocation to financial companies means the fund may be more sensitive to changes in interest rates and banking sector conditions.
GSID vs. SPDR S&P 500 ETF (SPY)
AUM1.06B
RegionDeveloped Markets
Expense Ratio0.20%
Beta0.76
IssuerGoldman Sachs
Inception DateMay 12, 2020
Dividend Yield2.5%
Asset ClassEquity
Index TrackedSolactive GBS Developed Markets ex North America Large & Mid Cap Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume36,035
30 Day Avg. Volume51,847
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
83.13Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering890
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GSID Summary
The Goldman Sachs MarketBeta International Equity ETF (GSID) is an exchange-traded fund that tracks the Solactive GBS Developed Markets ex North America Large & Mid Cap Index. It invests in many large and mid-sized companies outside the U.S. and Canada, across countries like Japan, the UK, and France. Well-known holdings include Toyota Motor and Nestlé. Someone might invest in GSID to diversify their portfolio internationally and spread risk across many sectors and countries. A key risk is that international stock prices can go up and down with global markets and currency changes.
How much will it cost me?The Goldman Sachs MarketBeta International Equity ETF (GSID) has an expense ratio of 0.20%, which means you’ll pay $2 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index rather than relying on active management strategies.
What would affect this ETF?Positive drivers for GSID could include strong growth in developed markets outside North America, particularly in sectors like financials and industrials, which make up a significant portion of the ETF's holdings. However, negative factors such as rising interest rates or economic slowdowns in these regions could impact corporate earnings and investor sentiment, especially for top holdings like ASML and Nestlé. Additionally, regulatory changes in key countries or global trade tensions could create uncertainty for the ETF's performance.
GSID Top 10 Holdings
GSID leans heavily on a mix of European and Asia-Pacific blue chips, with no single stock dominating the show. ASML has been a key engine, rising steadily and giving the fund a lift from the semiconductor and tech side, while HSBC and Commonwealth Bank add strength from a resurgent global banking backdrop. Health care names like AstraZeneca are quietly pulling their weight, but Roche and Novartis have been more mixed, occasionally losing steam. Toyota and Nestlé have lagged, acting as mild brakes on an otherwise broadly diversified, non-U.S. developed-markets portfolio.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.49% | $26.16M | €467.47B | 106.83% | 76 Outperform | |
| HSBC Holdings | 1.42% | $14.94M | £229.92B | 61.73% | 80 Outperform | |
| AstraZeneca | 1.34% | $14.06M | $302.77B | 38.76% | 80 Outperform | |
| Roche Holding AG | 1.33% | $13.95M | $329.96B | 30.11% | 73 Outperform | |
| Novartis AG | 1.29% | $13.50M | CHF212.28B | 26.39% | 80 Outperform | |
| Nestlé SA | 1.20% | $12.58M | CHF202.31B | -5.12% | 71 Outperform | |
| Shell (UK) | 1.16% | $12.19M | £184.12B | 35.31% | 73 Outperform | |
| Siemens | 0.96% | $10.11M | €185.54B | 24.13% | 74 Outperform | |
| Commonwealth Bank of Australia | 0.95% | $9.93M | AU$289.86B | 5.26% | 64 Neutral | |
| Toyota Motor | 0.94% | $9.89M | ¥40.70T | 17.52% | 80 Outperform |
GSID Technical Analysis
Positive
―
Price Trends
72.39
Positive
71.43
Positive
68.36
Positive
Market Momentum
0.68
Negative
53.36
Neutral
18.86
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GSID, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 72.47, equal to the 50-day MA of 72.39, and equal to the 200-day MA of 68.36, indicating a bullish trend. The MACD of 0.68 indicates Negative momentum. The RSI at 53.36 is Neutral, neither overbought nor oversold. The STOCH value of 18.86 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GSID.
GSID Peer Comparison
Comparison Results
Performance Comparison
GSID
Goldman Sachs MarketBeta International Equity ETF
73.24
14.68
25.07%
FENI
Fidelity Enhanced International ETF
―
―
―
DBEF
Xtrackers MSCI EAFE Hedged Equity ETF
―
―
―
BBIN
JPMorgan BetaBuilders International Equity ETF
―
―
―
EFAV
iShares MSCI EAFE Min Vol Factor ETF
―
―
―
IHDG
WisdomTree International Hedged Quality Dividend Growth Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents